Science Explorer Interactive view Map
Topic · Pulmonary and Respiratory Medicine

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis is a research topic within Pulmonary and Respiratory Medicine. Science Explorer counts 43k research works in it since 1950. 17.3% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the diagnosis, management, and pathogenesis of idiopathic pulmonary fibrosis (IPF), a progressive and fatal lung disease. It covers evidence-based guidelines, cellular and molecular mechanisms of fibrosis, therapeutic translation, treatment trials with drugs like pirfenidone and nintedanib, as well as the role of myofibroblasts and epithelial-mesenchymal transition in lung fibrosis.

  • Idiopathic Pulmonary Fibrosis
  • Fibrosis
  • Interstitial Lung Disease
  • TGF-ß
  • Myofibroblast
  • Pirfenidone
  • Nintedanib
  • Epithelial-Mesenchymal Transition
  • Lung Fibrosis
  • Bronchoalveolar Lavage
Research works
43k
fractional, since 1950
In the world top 10%
7.5k
per year above
Top-10% rate
17.3%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+46%
the tick is no change

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis research?

By volume, the United States and China publish the most (2.2k and 1.8k works in 2022–2025).

By volume, 2022–2025

  1. 1 United States 2.2k works
  2. 2 China 1.8k works
  3. 3 Japan 779 works
  4. 4 United Kingdom 508 works
  5. 5 Germany 409 works
  6. 6 India 399 works
  7. 7 Italy 390 works
  8. 8 France 343 works
  9. 9 Spain 326 works
  10. 10 South Korea 263 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 29.5%China: 24.1%Japan: 10.6%United Kingdom: 6.9%6 others listed: 28.9%30%largest
United States2,178 · 29.5%China1,778 · 24.1%Japan779 · 10.6%United Kingdom508 · 6.9%6 others listed2,129 · 28.9%

Shares of the rows listed above, not of the whole node.

Which institutions lead Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis research?

By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis research, followed by Imperial College London and University of Michigan.

By volume, 2022–2025

  1. 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 48 works
  2. 2 Imperial College LondonUnited Kingdom 42 works
  3. 3 University of MichiganUnited States 39 works
  4. 4 InsermFrance 35 works
  5. 5 Sichuan UniversityChina 34 works
  6. 6 University of Colorado DenverUnited States 31 works
  7. 7 University of PittsburghUnited States 27 works
  8. 8 University of Alabama at BirminghamUnited States 27 works
  9. 9 Yale UniversityUnited States 27 works
  10. 10 Capital Medical UniversityChina 27 works

Where is Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis research done?

The largest centres of Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis research in 2022–2025 are Beijing (China), Tokyo (Japan), London (United Kingdom) and Paris (France). Among places with at least 20 works in it, it is an unusually large share of all research in Hamamatsu.

Largest cities, 2022–2025

  1. 1 Beijing China 255 works
  2. 2 Tokyo Japan 180 works
  3. 3 London United Kingdom 178 works
  4. 4 Paris France 145 works
  5. 5 Seoul South Korea 135 works
  6. 6 Shanghai China 120 works
  7. 7 Guangzhou China 117 works
  8. 8 Chengdu China 99 works
  9. 9 New York United States 98 works
  10. 10 Boston United States 96 works

Where it is the local speciality

  1. HamamatsuJP · 26.8 works22×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis than the world average.

See Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis on the map

Where is the best place to study Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis?

Among universities, judged by research, Hamamatsu University School of Medicine, China Pharmaceutical University and University of Colorado Denver score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%60%mean 27.64%fractional works in this node (log) →share in the world top 10% →Hamamatsu University School of Medicine: 15, 22.5%China Pharmaceutical University: 10, 52.6%University of Colorado Denver: 31, 19.3%Beijing University of Chinese Medicine: 13, 28.6%Imperial College London: 42, 21.6%Nanjing Medical University: 21, 37.5%Capital Medical University: 27, 31.0%Chinese Academy of Medical Sciences & Peking Union Medical College: 48, 26.0%Medizinische Hochschule Hannover: 22, 14.2%University of Colorado Anschutz Medical Campus: 16, 23.1%China Pharmaceutical…Beijing University o…Hamamatsu University…University of Colora…
above the meannear itbelow it

One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 Hamamatsu University School of MedicineJapan 59.322.5%29.8×15 +164.9%
2 China Pharmaceutical UniversityChina 59.052.6%4.7×10 +234.1%
3 University of Colorado DenverUnited States 58.719.3%10.4×31 +54.3%
4 Beijing University of Chinese MedicineChina 56.928.6%8.1×13 +191.7%
5 Imperial College LondonUnited Kingdom 56.221.6%4.9×42 +85.5%
6 Nanjing Medical UniversityChina 53.837.5%4.4×21 +128.6%
7 Capital Medical UniversityChina 53.331.0%5.0×27 +108.2%
8 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 52.626.0%5.4×48 +19.3%
9 Medizinische Hochschule HannoverGermany 52.514.2%11.2×22 +46.3%
10 University of Colorado Anschutz Medical CampusUnited States 52.523.1%6.2×16 +268.3%

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis research growing?

Output in 2018–2022 was 46% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.